Register entry
- Registered sites
- 0
- Active NDC listings
- 13
- Labeller names
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1313 active NDC listings: 10 drug for further processing, 3 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 10, BULK INGREDIENT 3.
| Dosage form | NDCs |
|---|---|
| powder | 12 |
| tablet, coated | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| hovione limited | 6 |
| hovione llc | 4 |
| hovione llc | 3 |
Catalogue
Marketed products
13| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Aprocitentan (ACT-132577) | powder | 42052-1703BULK INGREDIENT |
| - | Avacopan | powder | 42052-1701BULK INGREDIENT |
| - | Belzutifan SDD | powder | 42052-1903DRUG FOR FURTHER PROCESSING |
| - | Elexacaftor Tezacaftor Ivacaftor | tablet, coated | 42052-2001DRUG FOR FURTHER PROCESSING |
| - | Enzalutamide SDD Hov A | powder | 42052-1901DRUG FOR FURTHER PROCESSING |
| - | Ivacaftor spary dried dispersion | powder | 51473-1901DRUG FOR FURTHER PROCESSING |
| - | Ivosidenib solid dispersion intermediate | powder | 42052-1902DRUG FOR FURTHER PROCESSING |
| - | Ledipasvir SDD 50% w/w | powder | 51473-1902DRUG FOR FURTHER PROCESSING |
| - | Omaveloxolone | powder | 42052-1702BULK INGREDIENT |
| - | Orforglipron SDD | powder | 51473-1904DRUG FOR FURTHER PROCESSING |
| - | Orforglipron SDD | powder | 51473-1905DRUG FOR FURTHER PROCESSING |
| - | Suzetrigine SDD | powder | 51473-1906DRUG FOR FURTHER PROCESSING |
| - | Velpatasvir SDD 50% w/w | powder | 51473-1903DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing orforglipron sdd
- HOVIONE FARMACIENCIA, S.A.4 sites · 47 NDC
Enquiry
Common questions
- Is Hovione LLC FDA approved?
- Hovione LLC holds no registered establishment of its own; 13 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Hovione LLC make?
- 13 products are listed under Hovione LLC in the openFDA NDC Directory, most often as powder; tablet, coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.